Health Catalyst (HCAT) Misses Q2 EPS by 63c

Health Catalyst (NASDAQ: HCAT) reported Q2 EPS of ($0.59), $0.63 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $80.7 million versus the consensus estimate of $80.66 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Our Bond (OBAI) files for 10M share offering by selling stockholders
• Hims & Hers chief accounting officer to resign in October